非鳞状非小细胞肺癌的临床试验
总计13310个结果
-
Ontario Clinical Oncology Group (OCOG)Roche Pharma AG完全的
-
Asan Medical CenterEli Lilly and Company; Korean Cancer Study Group未知
-
Achieve Life Sciences完全的
-
Sun Farm CorporationNational Center for Complementary and Integrative Health (NCCIH)未知
-
Rambam Health Care CampusWeleda AG完全的
-
Taipei Veterans General Hospital, Taiwan完全的
-
Samsung Medical Center未知
-
Hellenic Oncology Research GroupUniversity Hospital of Crete完全的
-
SBPharmaceutical IND, Co., LTD未知
-
Shanghai Nancy Medical Sci-Tech Co. LtdSichuan Cancer Hospital and Research Institute未知
-
Simcere Pharmaceutical Co., LtdDaping Hospital and the Research Institute of Surgery of the Third Military Medical University未知
-
Third Military Medical University未知
-
Third Military Medical University未知
-
Maastricht Radiation Oncology完全的
-
Zhejiang Cancer Hospital未知
-
Eli Lilly and Company完全的
-
Hellenic Oncology Research GroupUniversity Hospital of Crete完全的
-
Taipei Medical University HospitalPfizer; TTY Biopharm未知
-
Eli Lilly and Company完全的
-
Dana-Farber Cancer InstituteBristol-Myers Squibb; Massachusetts General Hospital; Beth Israel Deaconess Medical Center; Brigham...完全的
-
National Taiwan University Hospital未知
-
Hoffmann-La Roche完全的
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)终止IIIA 期非小细胞肺癌 | IIIB 期非小细胞肺癌 | 复发性非小细胞肺癌 | IV 期非小细胞肺癌 | 不可切除的恶性肿瘤 | 转移性肿瘤 | 复发性肿瘤美国
-
Albert Einstein College of MedicineNational Cancer Institute (NCI)完全的
-
Emory UniversityBristol-Myers Squibb撤销复发性非小细胞肺癌 | IV 期非小细胞肺癌美国
-
National Cancer Institute (NCI)完全的复发性非小细胞肺癌 | IV 期非小细胞肺癌 AJCC v7美国
-
Chugai PharmaceuticalJapan Lung Cancer Society完全的
-
Chugai PharmaceuticalJapan Lung Cancer Society完全的